Intrastromal corneal ring implant safe

Article

Intrastromal corneal ring segment (ICRS) implantation is safe and offers good visual and refractive outcomes in patients with paracentral keratoconus.

Intrastromal corneal ring segment (ICRS) implantation is safe and offers good visual and refractive outcomes in patients with paracentral keratoconus.

Dr Jose F. Alfonso and his team, based in Fernández-Vega Ophthalmological Institute, Oviedo, Spain, evaluated 56 eyes of 49 patients. The cohort study measured Snellen uncorrected and corrected distance visual acuities (UDVA and CDVA), along with residual refractive errors before implantation and six months after implantation. The ICRS was implanted into tunnels created by femtosecond laser.

Mean preoperative UDVA was 0.17 ± 0.14 and 0.41 ± 0.28 six months postoperatively. Mean CDVA was 0.70 ± 0.18 and 0.80 ± 0.17 pre and postoperatively, respectively.

Of the patients assessed, five eyes lost one lines of CDVA, 17 eyes had the same CDVA at baseline, 15 eyes gained one line, nine eyes gained two lines, seven eyes gained three lines and three eyes gained four lines.

ICRS implantation is a predictable and safe procedure for refractive correction in paracentral keratoconus cases.

The abstract can be found in the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.